131 related articles for article (PubMed ID: 20469674)
1. [Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy].
Pal'tsev AI; Sharapov IV; Gorbunova EN; Khomchenko TN; Kurganova IV; Soldatova GS; Eremina AA; Nikolaev IuA
Eksp Klin Gastroenterol; 2009; (8):19-25. PubMed ID: 20469674
[TBL] [Abstract][Full Text] [Related]
2. [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis].
Váli L; Blázovics A; Fehér J
Orv Hetil; 2005 Nov; 146(47):2409-14. PubMed ID: 16398154
[TBL] [Abstract][Full Text] [Related]
3. A new approach to drug therapy in non-alcoholic steatohepatitis (NASH).
Fehér J; Lengyel G
J Int Med Res; 2003; 31(6):537-51. PubMed ID: 14708419
[TBL] [Abstract][Full Text] [Related]
4. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
Ki SH; Choi JH; Kim CW; Kim SG
Chem Biol Interact; 2007 Aug; 169(2):80-90. PubMed ID: 17606256
[TBL] [Abstract][Full Text] [Related]
5. [Metadoxyl in combined treatment of alcohol damage to the liver].
Vedrova NN; Gnezdilova NIu
Klin Med (Mosk); 2001; 79(4):56-8. PubMed ID: 11496744
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
7. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Miele L; Forgione A; Gasbarrini G; Grieco A
Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study].
Sergiacomo L; Ciancaglini R; Orlando D; Delle Monache G; Pesa O
Clin Ter; 1986 Oct; 119(2):133-41. PubMed ID: 3539468
[No Abstract] [Full Text] [Related]
10. [Histopathological diagnose of non-alcoholic and alcoholic fatty liver disease].
Tannapfel A; Denk H; Dienes HP; Langner C; Schirmacher P; Trauner M; Flott-Rahmel B
Z Gastroenterol; 2010 Apr; 48(4):486-98. PubMed ID: 20352596
[TBL] [Abstract][Full Text] [Related]
11. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and therapy in NASH].
Tokushige K
Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
[TBL] [Abstract][Full Text] [Related]
13. Silent non-alcoholic fatty liver disease-a clinical-histological study.
Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
[TBL] [Abstract][Full Text] [Related]
14. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
15. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
16. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
[TBL] [Abstract][Full Text] [Related]
17. [Non-alcoholic steato-hepatitis].
Linhart HG
Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
[TBL] [Abstract][Full Text] [Related]
18. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
19. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
20. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.
Fernández-Miranda C; Pérez-Carreras M; Colina F; López-Alonso G; Vargas C; Solís-Herruzo JA
Dig Liver Dis; 2008 Mar; 40(3):200-5. PubMed ID: 18261709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
